Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
HitIQ Limited ( (AU:HIQ) ) has shared an update.
HitIQ reported a sharp acceleration in commercial traction for the March quarter, with sales rising to $294,000 from $91,000 as the PROTEQT™ mouthguard platform secured national retail distribution through Rebel, Chemist Warehouse Marketplace, Amazon Australia and NARTA partners. A coordinated marketing push via Sports Entertainment Network, timed to pre-season demand, and early international sales to a Scottish rugby club and Australian universities underscored growing adoption across retail, direct-to-consumer, community sport and elite programs.
To support its scale-up, the company formed a high-profile advisory board with expertise in neuroscience, elite sport and MedTech commercialisation, while tightening governance through board and company secretary changes. HitIQ also advanced funding discussions and capital management initiatives to finance inventory, marketing and operational expansion, signalling a focus on improving unit economics, broadening international distribution and deepening penetration into institutional, insurance and defence-aligned markets as it transitions toward higher recurring revenues.
More about HitIQ Limited
HitIQ Limited is an Australian sports technology and MedTech company focused on head-impact monitoring and protective equipment, with its flagship consumer product PROTEQT™ targeting athletes across community and elite sports. The company distributes through major retail, e-commerce and specialist channels, positioning itself at the intersection of sports safety, health technology and data-driven performance.
Average Trading Volume: 464,771
Technical Sentiment Signal: Sell
Current Market Cap: A$9.83M
See more insights into HIQ stock on TipRanks’ Stock Analysis page.